BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8740360)

  • 1. X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily.
    Dhanaraj V; Ye QZ; Johnson LL; Hupe DJ; Ortwine DF; Dunbar JB; Rubin JR; Pavlovsky A; Humblet C; Blundell TL
    Structure; 1996 Apr; 4(4):375-86. PubMed ID: 8740360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing inhibitors of the metalloproteinase superfamily: comparative analysis of representative structures.
    Dhanaraj V; Ye QZ; Johnson LL; Hupe DJ; Ortwine DF; Dunbar JB; Rubin JR; Pavlovsky A; Humblet C; Blundell TL
    Drug Des Discov; 1996 Apr; 13(3-4):3-14. PubMed ID: 8874040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
    Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
    J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1.
    Zhang X; Gonnella NC; Koehn J; Pathak N; Ganu V; Melton R; Parker D; Hu SI; Nam KY
    J Mol Biol; 2000 Aug; 301(2):513-24. PubMed ID: 10926524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design.
    Grams F; Reinemer P; Powers JC; Kleine T; Pieper M; Tschesche H; Huber R; Bode W
    Eur J Biochem; 1995 Mar; 228(3):830-41. PubMed ID: 7737183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453.
    Kohno T; Hochigai H; Yamashita E; Tsukihara T; Kanaoka M
    Biochem Biophys Res Commun; 2006 May; 344(1):315-22. PubMed ID: 16603129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of the catalytic domain of human stromelysin-1 complexed to a potent, nonpeptidic inhibitor.
    Li YC; Zhang X; Melton R; Ganu V; Gonnella NC
    Biochemistry; 1998 Oct; 37(40):14048-56. PubMed ID: 9760240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
    Van Doren SR; Kurochkin AV; Hu W; Ye QZ; Johnson LL; Hupe DJ; Zuiderweg ER
    Protein Sci; 1995 Dec; 4(12):2487-98. PubMed ID: 8580839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin.
    Dunten P; Kammlott U; Crowther R; Levin W; Foley LH; Wang P; Palermo R
    Protein Sci; 2001 May; 10(5):923-6. PubMed ID: 11316871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
    Nar H; Werle K; Bauer MM; Dollinger H; Jung B
    J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive conformation of a potent stromelysin inhibitor determined by X-nucleus filtered and multidimensional NMR spectroscopy.
    Gonnella NC; Li YC; Zhang X; Paris CG
    Bioorg Med Chem; 1997 Dec; 5(12):2193-201. PubMed ID: 9459017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.
    Finzel BC; Baldwin ET; Bryant GL; Hess GF; Wilks JW; Trepod CM; Mott JE; Marshall VP; Petzold GL; Poorman RA; O'Sullivan TJ; Schostarez HJ; Mitchell MA
    Protein Sci; 1998 Oct; 7(10):2118-26. PubMed ID: 9792098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NMR structure of the inhibited catalytic domain of human stromelysin-1.
    Gooley PR; O'Connell JF; Marcy AI; Cuca GC; Salowe SP; Bush BL; Hermes JD; Esser CK; Hagmann WK; Springer JP
    Nat Struct Biol; 1994 Feb; 1(2):111-8. PubMed ID: 7656014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.
    Park HI; Jin Y; Hurst DR; Monroe CA; Lee S; Schwartz MA; Sang QX
    J Biol Chem; 2003 Dec; 278(51):51646-53. PubMed ID: 14532275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition.
    Brandstetter H; Grams F; Glitz D; Lang A; Huber R; Bode W; Krell HW; Engh RA
    J Biol Chem; 2001 May; 276(20):17405-12. PubMed ID: 11278347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.
    Jacobson IC; Reddy PG; Wasserman ZR; Hardman KD; Covington MB; Arner EC; Copeland RA; Decicco CP; Magolda RL
    Bioorg Med Chem Lett; 1998 Apr; 8(7):837-42. PubMed ID: 9871551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivity.
    Pavlovsky AG; Williams MG; Ye QZ; Ortwine DF; Purchase CF; White AD; Dhanaraj V; Roth BD; Johnson LL; Hupe D; Humblet C; Blundell TL
    Protein Sci; 1999 Jul; 8(7):1455-62. PubMed ID: 10422833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller.
    Li J; Brick P; O'Hare MC; Skarzynski T; Lloyd LF; Curry VA; Clark IM; Bigg HF; Hazleman BL; Cawston TE
    Structure; 1995 Jun; 3(6):541-9. PubMed ID: 8590015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structures of stromelysin complexed to thiadiazole inhibitors.
    Stockman BJ; Waldon DJ; Gates JA; Scahill TA; Kloosterman DA; Mizsak SA; Jacobsen EJ; Belonga KL; Mitchell MA; Mao B; Petke JD; Goodman L; Powers EA; Ledbetter SR; Kaytes PS; Vogeli G; Marshall VP; Petzold GL; Poorman RA
    Protein Sci; 1998 Nov; 7(11):2281-6. PubMed ID: 9827994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor.
    Borkakoti N; Winkler FK; Williams DH; D'Arcy A; Broadhurst MJ; Brown PA; Johnson WH; Murray EJ
    Nat Struct Biol; 1994 Feb; 1(2):106-10. PubMed ID: 7656013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.